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IKKβCXCL12 and its unique receptor CXCR4, is critical for the homing of a variety of cell lineages during both develop-
ment and tissue repair. CXCL12 is particularly important for the recruitment of hemato/lymphopoietic cells to
their target organs. In conjunction with the damage-associated alarmin molecule HMGB1, CXCL12 mediates
immune effector and stem/progenitor cell migration towards damaged tissues for subsequent repair. Previously,
we showed that cellmigration toHMGB1 simultaneously requires both IKKβ and IKKα-dependentNF-κB activation.
IKKβ-mediated activationmaintains sufﬁcient expression of HMGB1's receptor RAGE,while IKKα-dependent NF-κB
activation ensures continuous production of CXCL12, which complexes with HMGB1 to engage CXCR4. Here using
ﬁbroblasts and primary mature macrophages, we show that IKKβ and IKKα are simultaneously essential for cell
migration in response to CXCL12 alone. Non-canonical NF-κB pathway subunits RelB and p52 are also both essential
for cell migration towards CXCL12, suggesting that IKKα is required to drive non-canonical NF-κB signaling. Flow
cytometric analyses of CXCR4 expression show that IKKβ, but not IKKα, is required to maintain a critical threshold
level of this CXCL12 receptor. Time-lapse video microscopy experiments in primary MEFs reveal that IKKα is
required both for polarization of cells towards a CXCL12 gradient and to establish a basal level of velocity towards
CXCL12. In addition, CXCL12 modestly up-regulates IKKα-dependent p52 nuclear translocation and IKKα-
dependent expression of the CXCL12 gene. On the basis of our collective results we posit that IKKα is needed to
maintain the basal expression of a critical protein co-factor required for cell migration to CXCL12.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The chemokine CXCL12, also known as stromal cell derived factor 1
(SDF-1), regulates the migration and homing of stem/progenitor cells.
Along with its unique receptor, CXCR4, CXCL12 exerts a pivotal role
during embryogenesis for lymphopoiesis, myelopoiesis, cardiogenesis,B1, High Mobility Group Box 1;
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edars Sinai Medical Center, Los
A.angiogenesis and neurogenesis [1]. In postnatal life, CXCL12/CXCR4 sig-
naling plays an important role in the homing of hematopoietic and
lymphopoietic cells, and in the targeted trafﬁcking of stem/progenitor
cells during tissue repair and/or regeneration. Moreover, since CXCR4
is expressed by several types of cancer cells, CXCL12 exerts pleiotropic
effects regulating processes essential to tumor cellmetastasis {reviewed
in [2]}. Binding of CXCL12 to CXCR4 activates multiple signaling path-
ways including MAPK p42/44, Jak/STAT and the PI-3K-AKT-NF-κB axes
[3–7]. CXCR4 expression is regulated byNF-κB and the CXCR4 promoter
contains p50/p65 binding sites [6,8]. Moreover, CXCL12 stimulation of
mesoangioblasts (blood vessel stem cells) triggers NF-κB p65 nuclear
translocation, which is required for mesoangioblast migration in
response to CXCL12 [9].
NF-κB transcription factors mediate stress-like inﬂammatory
responses, participate in developmental programming and regulate
normal andmalignant cell growth and survival [10–12]. In the canonical
NF-κB signaling pathway, speciﬁc NF-κB subunits are released from
their inhibitory IκBs by virtue of the serine–threonine kinase activities
of the IKK signalosome. In response to extracellular stress signals,
IκBα is phosphorylated by the IKK complex thereby targeting it for
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IκB results in exposure of the nuclear localization sequence of NF-κB,
leading to nuclear translocation of NF-κB hetero-dimers (including
p65/RelA:p50 and c-Rel:p50) and the subsequent activation of their
target genes [13]. The IKK complex consists of two serine-threonine
kinases, IKKα and IKKβ, and NEMO/IKKγ, a regulatory or docking
protein that facilitates IKK complex assembly and the regulated trans-
mission of upstream activating signals to IKKα and IKKβ [13–15].
Most extracellular stimuli cause only transient IKK activation andmech-
anisms to limit IKK activity are physiologically important because
persistent NF-κB activity is associated with numerous pathological
conditions.
IKKβ is almost always the IκBα kinase in vivo, although IKKα can in-
frequently assume this role [16,17]. In contrast to IKKβ, IKKα functions
to attenuate or resolve acute inﬂammatory responses bymore than one
mechanism [18–20] and is the essential kinase activator of the non-
canonical NF-κB pathway [21]. Upon activation by the NF-κB inducing
kinase (NIK), IKKα phosphorylates speciﬁc serine residues in the
carboxy-terminal domain of NFκB2/p100, leading to its proteasomal
processing into the mature NF-κB p52 subunit and subsequent nuclear
translocation of p52-RelB hetero-dimers [22]. Non-canonical NF-κB ac-
tivation also requires new protein synthesis and thus is not activated
as rapidly as the classical IKKβ/NEMO dependent pathway. Moreover,
only a few extracellular signals have been identiﬁed that can activate
the NIK-IKKα non-canonical NF-κB pathway (including CD40L, LTβ
and BAFF) [11]. Interestingly, extracellular stimuli resulting in cellular
responses that require sustained NF-κB induction appear to activate
both the IKKβ/NEMO and NIK/IKKα signaling pathways [23–26]. In
addition to driving nuclear translocation of RelB/p52 heterodimers,
the IKKα dependent non-canonical pathway has also been reported to
activate p65/p52 [25] and a subset of p50/p65 heterodimers (seques-
tered in the cytoplasm in p100 complexes) [26], suggesting that IKKα
can also contribute to certain pro-inﬂammatory responses.
Although a host of cytokines and chemokines are targets of NF-κB
transcription factors, only a paucity of data (and only in either immor-
talized or engineered cell lines in vitro) has suggested that canonical
NF-κB activation in migrating cells may contribute to their chemotactic
responses [27–29]. We have previously shown that both the IKKβ-
driven canonical and the IKKα-dependent p52/RelB non-canonical NF-
κB pathways are simultaneously critical for cell migration to HMGB1
[30,31]. Even though it is well established that HMGB1 [32–34] and
CXCL12 [6,8,35–38] both activate the canonical NF-κB pathway, until
our recent published work, it was not known if their unique chemotac-
tic properties require cells to express speciﬁcNF-κB target genes needed
for cells to migrate towards these two chemoattractants. Here we show
that IKKβ and IKKα mediated canonical and non-canonical NF-κB
signaling pathways are essential for the migration of ﬁbroblasts and
macrophages in response to CXCL12. IKKβ, but not IKKα, is required to
maintain a threshold level of cell surface CXCR4, which is needed to
maintain CXCL12-elicited chemotaxis. In conjunction with the latter
functional role of IKKβ, IKKα, (via its unique function to activate the
RelB/p52 non-canonical NF-κB pathway), is critically important for the
initial polarization and velocity of cell movement towards a CXCL12
gradient.2. Materials and methods
2.1. Ethics statement
All animal work was approved by the IACUC committee of Stony
Brook University in accordance with USA NIH guidelines for the use of
animals in biomedical research. These studies utilized only in vitro
experiments with primary embryonic ﬁbroblasts (MEFs) or bone
marrow progenitors (BMPs) isolated from the femurs of adult mice
and subsequently differentiated to mature macrophages in vitro.Mouse pups or adult mice were euthanized by an IACUC approved pro-
tocol prior to the isolation of MEFS or BMPs.
2.2. Conditional and inducible IKKα KO mice
Mice with IKKα alleles ﬂanked by LoxP recombination sites (IKKαf/f
mice) that express Cre recombinase under the control of the macro-
phage lysozyme (MLys) promoter only in mature macrophages (MΦ)
and neutrophils (IKKαf/f:MLysCre mice) [30]. Alternatively, other mice
express a tamoxifen (4-OHT) inducible Cre gene (IKKαf/f:CreERT2 mice)
that have been previously described [30]. All animalworkwas approved
by Stony Brook University's IACUC committee in accordance with NIH
guidelines.
2.3. Reagents
Recombinant murine CXCL12/SDF-1 was obtained from PeproTech
(Rocky Hill, NJ). Human recombinant PDGF and human recombinant
complement C5a were purchased from R&D Systems (Minneapolis,
MN); puriﬁed ﬁbronectin was obtained from Roche (Indianapolis, IN).
Tamoxifen (4-hydroxytamoxifen, 4-OHT) was obtained from Sigma-
Aldrich (St. Louis, MO); Alexaﬂuor 647-conjugated anti-mouse CXCR4
antibody was purchased from Biolegend (San Diego, CA). All materials
for the in vitro cell migration assays were obtained from Neuroprobe
(Cabin John, MD) and included 48 well microchemotaxis chamber and
8 μm pore size cellulose nitrate ﬁlters (for macrophages) and 8 μm
pore size PVP-free polycarbonate ﬁlters (for ﬁbroblasts).
2.4. Cells and tissue culture
Immortalized WT, IKKα KO, p52 KO and RelB KO MEFs were main-
tained as previously described in Dulbecco's Modiﬁed Eagle's Medium
(DMEM) with 10% Fetal Bovine Serum (FBS), 100 U/ml penicillin and
100 μg/ml streptomycin. Bone marrow progenitors from the femurs of
IKKα WT (IKKαf/f), IKKαf/f:MLysCre and IKKβf/f:MLysCre adult mice
were differentiated to MΦ in M-CSF conditioned DMEM/10%FBS for
7 days as previously described [30]; and the loss of IKKα or IKKβ in my-
eloid cell progenitors does not affect the efﬁciency of their differentia-
tion to mature macrophages or neutrophils [30]. Primary MEFs
were isolated from 5–6 day old IKKαf/f:CreERT2mouse embryos also as
described in prior reports [30,31].
2.5. Retroviral transduction
IKKβ and IKKα KO MEFs were stably transduced with a Moloney
murine retroviral vector containing a murine CXCR4 cDNA expressed
as part of a bi-cistronic IRES-puromycin expression cassette [39].
Murine CXCR4 cDNA was subcloned upstream of an IRES-puromycin
cassette in the BIPmurineMoloney retroviral vector [40,41]. The gener-
ation of amphotyped viruses, infection of cells and selection of stable
puromycin resistant cell populations have been previously described
[30,40,41].
2.6. In vitro chemotaxis assays
Chemotaxis assays with MEFs andMΦwere performed as previously
described [30,31]. MEF and MΦmigration assays were performed with
5 × 104 and 1 × 105 cells respectively per well of a 48 well micro-
chemotaxis (Boyden-type) chamber. Chemotaxis of MEFs utilized 8 μm
pore size PVP-free polycarbonate ﬁlters pre-coated with ﬁbronectin
(50 μg/ml) and chambers were incubated for 3 h at 37 °C. MEFs were
quantiﬁed as the number of migrated cells per high power ﬁeld
(400×), and the background control (serum-freemedia) was subtracted
so data are expressed as net migrated cells. Macrophage chemotaxis
employed cellulose nitrateﬁlters (8 μmpore size) in chambers incubated
for 3 h at 37 °C. Distances ofmacrophagesmigrated into the nitrocellular
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described [42]. Macrophage migration data is presented as net
cell movement per 3 h. In our experience and prior work [30,31], nitro-
cellulose ﬁlters, which measure the leading front distance of migrating
cells, is a superior and more sensitive technique for myeloid cells
(including macrophages, monocytes and neutrophils) than counting
cells per high power ﬁeld with polycarbonate ﬁlters. Mesenchymal
cells such as ﬁbroblasts do not migrate into the nitrocellulose ﬁlters,
even when employing very large pore size (12 μm) ﬁlters. For ﬁbroblast
migration assays we used thin (10 μm depth) polycarbonate ﬁlters with
straight 8 μm holes to count cells adhering to the underside of the ﬁlter.
For IBIDI time-lapse chemotaxis experiments, cells of different geno-
types were distinguished from each other by staining with 500 nM
Green CMFDA or 500 nM Orange CMRA CellTracker™(Invitrogen) for
15 min in a humidiﬁed tissue culture incubator. Labeled cells were
washed, resuspended at 4 × 105 cells/ml in DMEM (phenol red free)
+0.1% BSA, mixed and placed (300 μl) in a μ-Slide (IBIDI/Integrated
BioDiagnostics Inc.) pre-coated with 50 μg/ml ﬁbronectin. After cells
had ﬁrmly attached to the substratum, slides were laid on a 37 °C hu-
midiﬁed stage of an UltraVIEW ERS Spinning Disk confocal microscope
(Perkin Elmer). A 0–30 μg/ml CXCL12 gradient, mixed with ﬂuorescent
beads (Molecular Probes) for microscope viewing, was allowed to form
in the chamber's channel as described [43]. Pictures of cells at the edge
of the gradient were captured every 2 min for up to 3 h (microscope
objective Zeiss, 5× magniﬁcation, numerical aperture 0.15; EM-CCD
Hamamatsu C9100 Camera; UltraVIEW ERS acquisition software).
Directional tracks are deﬁned as those with ending points closer to the
CXCL12 source compared to their starting points, whereas non-
directional tracks are the opposite. Indeterminate tracks starting
and ending at the same distance from the CXCL12 gradient (moving
laterally) are also considered non-directional tracks. Cell tracks were
analyzed with ImageJ software (Rasband, W.S., ImageJ, U. S. National
Institutes of Health, Bethesda, MD, USA, http://rsb.info.nih.gov/ij/,
1997–2008).
2.7. Flow cytometry
Primary mature macrophages were detached from cell culture
dishes by incubation in DPBS containing 10% EDTA for 10 min at 4 °C.
Cells were resuspended at 5 × 106 cells per ml in ﬂow cytometry stain-
ing buffer (DPBS + 1% BSA + 0.02% NaN3); and 5 × 105 cells were
blocked with 2 μg of mouse IgG for 15 min on ice and subsequently
stained with 1 μg of Alexaﬂuor 647-conjugated anti-mouse CXCR4 anti-
body (Biolegend) for an additional 15 min on ice. Cells were washed
twice with ﬂow cytometry staining buffer and then ﬁxed in 2% parafor-
maldehyde prior to analysis. For intracellular staining, macrophages
were permeabilized by washing twice with 1× BD perm/wash buffer
(BD Biosciences, San Jose, CA). Next, cells were resuspended in 100 μl
of perm/wash buffer and blocked with 2 μg of mouse IgG for 30 min
on ice. Cells were stained with 1 μg of ﬂuorophore conjugated anti-
CXCR4 antibody for 30 min on ice and then washed twice with perm/
wash buffer and ﬁxed with 2% paraformaldehyde. Flow cytometric
data were collected using a BD FACS Calibur II ﬂow cytometer and the
data were analyzed using FlowJo (Tree Star Inc., Ashland, OR). As a
negative control for the speciﬁcity of the anti-CXCR4 antibody, cells
were stained with an isotype control antibody conjugated with the
same ﬂuorophore.
2.8. Immunoblotting and cell fractionation
Immunoblotting and the preparation of nuclear and cytoplasmic
fractions were performed as previously described [30,41]. HRP conju-
gated secondary antibody signals were detected with an enhanced
chemiluminescent detection kit (GE Healthcare, Piscataway, NJ). Nucle-
ar p52 levels were normalized with respect to nuclear lamin B1. Film
images were acquired with a Fluor-S Multimager (BioRad). Scannedprotein bands were quantiﬁed with Quantity One 4.5.0 software
(BioRad) and processed with Adobe Creative Suite.
2.9. Sybr green real time RT-PCR assays
Total cell RNAs were prepared and Sybr green real time RT-PCR was
performed and quantiﬁed as previously described [30] Forward (F) and
reverse (R) PCR primer sequences were as follows:
Gapdh F (GCTCACTGGCATGGCCTTC),
Gapdh R (CCTTCTTGATGTCATCATACTTGGC);
Cxcl12 F (GCACGGCTGAAGAACAACAAC),
Cxcl12 R (TTCCTCGGGCGTCTGACTC).
2.10. Statistical analysis
P values were determined with either Prism V4.0 Software or InStat
(both obtained from GraphPad Inc., San Diego, CA) to 4 signiﬁcant
ﬁgures by two tailed Student's t test, one way or two way ANOVA
with Tukey's multiple comparisons post test as indicated in the ﬁgure
legends of speciﬁc experiments.
3. Results
3.1. The IKKα and IKKβ driven NF-κB pathways are both required for cell
migration in response to CXCL12
We have previously shown that the NF-κB canonical pathway is
required for cell migration to HMGB1 and CXCL12 but not to other
cytokines [9], and that the IKKβ and IKKα-driven canonical and non-
canonical NF-κB pathways are both essential for cell migration to
HMGB1 [30,31]. Akin to our ﬁndings with HMGB1-mediated cell migra-
tion, we ﬁnd that IKKβ and IKKα are essential for the migration of
immortalized MEFs (Fig. 1A) but not to a PDGF positive control. To
determine if this was also a property of other cell types lacking IKKα
or IKKβ, we performed analogous experiments with mature primary
macrophages differentiated from bone marrow progenitors of IKKβf/f;
MLysCre and IKKαf/f;MLysCremice, in which IKKβ or IKKα respectively
are absent in mature myeloid cells. Immunoblots demonstrating that
IKKβ and IKKα proteins are not expressed by mature myeloid cells
derived from thesemicewere reported previously [30] and other repre-
sentative examples are shown in Suppl. Fig. 1A. Indeed, akin to IKKβ and
IKKα KO MEFs, mature macrophages derived from these mice also are
unable to migrate to CXCL12 as compared to mature macrophages
from WT mice. In contrast, macrophages from each of these 3 mouse
strains migrate equally well to the positive control, complement
activation fragment C5a (Fig. 1B). The essential IKKα requirement
for chemotaxis in response to CXCL12 is functionally linked to the
non-canonical NF-κB pathway, because MEFs lacking either the non-
canonical NF-κB subunits p52 or RelB also failed to migrate towards
CXCL12, while their ability to respond to PDGF was similar to that of
WT MEFs (Fig. 1C).
3.2. IKKβ is required to maintain sufﬁcient levels of CXCR4
Since the CXCL12 receptor CXCR4 is a direct target of the canonical
NF-κB pathway [6,8], we performed experiments to investigate if the
essential requirement for IKKβ was linked to signiﬁcant differences of
CXCR4 expression levels in WT and IKKβ KO cells. To this end, we
analyzed the relative expression levels of total cellular and cell surface
CXCR4 protein in WT and conditional IKKβ KO IKKβf/f;MLysCremature
macrophages by quantitative ﬂow cytometry. We performed this
analysis by ﬂow cytometry, and not by immunobloting nor by
immunoﬂuoresence staining of cells, because only ﬂow cytometry pro-
vides a quantitative assessment of CXCR4 expression on a single cell
basis. This analysis of total cellular and cell surface levels of CXCR4 in
Fig. 1. IKKα, IKKβ and NF-κB p52 and RelB are each required for cell migration in response to CXCL12. (A) Chemotaxis of immortalized WT, IKKβ KO and IKKα KOMEFs (5 × 104 cells) was
evaluatedusing a 48wellmicrochemotaxis chambers as previously described [30]. Cellswere allowed to respond to CXCL12 (50ng/ml), serum-freemedia (SF) as thenegative control and PDGF
(10 ng/ml) as the positive control for robust cell migration. The number of cells that traversed an 8 μm pore-size polycarbonate ﬁlter after a 3 h incubation at 37 °C were counted using a mi-
croscope at 400× magniﬁcation. Numbers represent mean ± SEM of cells per high power ﬁeld (HPF), n = 4, ** indicates p b 0.01, ns = not signiﬁcant. PDGF served as a positive migration
control for all 3 cell backgrounds but only to illustrate that each cell type migrate towards PDGF but in contrast to WT MEFs, IKKα KO and IKKβ KO cells do not migrate towards CXCL12.
The absolute degrees of migration of WT, IKKα KO and IKKβ KO MEFs towards PDF are somewhat different from each other, which likely reﬂects intrinsic properties of these different cell
lines. Thus, statistical analyses of the results in Fig. 1A were done for WT MEFs exposed to media vs. CXCL12: IKKα KO MEFs exposed to media vs. CXCL12; and IKKβ KO MEFs exposed to
media vs. CXCL12. (B) Primary mature WT and conditional IKKα and IKKβ KO macrophages (105 cells) were exposed to CXCL12 (50 ng/ml) or C5a (2 nM) as a positive control in 48 well
microchemotaxis chambers for 3 h as previously described [30]. Data is presented as net migration distance per 400× ﬁeld after subtracting basal migration in serum free media (n = 3–4).
Mean value of WT macrophage basal migration towards serum free media control was 35 ± 2.6 μm. Statistical signiﬁcance is indicated, ns = not signiﬁcant. (C) Chemotaxis of WT, NF-κB
p100/p52 KO and NF-κB RelB KO MEFs (5 × 104 cells) was evaluated using a 48 well microchemotaxis chambers as previously described [30]. Cells were allowed to respond to CXCL12
(50 ng/ml), serum-free media (SF) as the negative control and PDGF (10 ng/ml) as the positive control for robust cell migration. The number of cells that traversed an 8 μmpore-size polycar-
bonate ﬁlter after a 3 h incubation at 37 °C were counted using a microscope at 400× magniﬁcation. Numbers represent mean ± SEM of cells per high power ﬁeld (HPF), n = 4, ** indicates
p b 0.01, ns = not signiﬁcant.
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expression levels of CXCR4 were signiﬁcantly reduced in IKKβ KO cells
relative to their WT counterparts (Fig. 2A). Since cell surface CXCR4 is
internalized upon binding to its ligand CXCL12 [44,45], we observed a
signiﬁcantly greater reduction of cell surface CXCR4 with IKKβ KO
Macs compared toWTMacs after 2 h of exposure to CXCL12 (see results
shown as fold change inMFIwith anwithout CXCL12 treatment for total
and cell surface levels of CXCR4 in Fig. 2A&B respectively). Similar to our
observationswith primarymaturemacrophages,we also noted reduced
cell surface CXCR4 levels in IKKβ KO MEFs compared to WT or NF-κB
p52 KO MEFs when cells were treated with CXCL12 (Supplementary
Fig. 2). Representative quantitative ﬂow cytometry experiments com-
paring cell surface and total CXCR4 expression in un-stimulated versus
CXCL12-treated cells are shown in Supplementary Fig. 3. In addition,
these quantitative experiments demonstrate that total levels of CXCR4
in unstimulated IKKβ KO primarymaturemacrophages are signiﬁcantly
reduced compared to their WT counterparts (Supplementary Fig. 3C).
To investigate if the IKKβ-dependent maintenance of a critical,threshold level of cell surface CXCR4 is functionally linked to IKKβ's
essential requirement for cell migration to CXCL12, we enforced the ex-
pression ofmurine CXCR4 in both IKKβ and IKKαKOMEFs by stable ret-
roviral transduction and evaluated their migration in response to
CXCL12 by quantitative ﬂow cytometry analysis. The enhanced cell sur-
face expression of CXCR4 in these cells, as well as the speciﬁcity of the
anti-CXCR4 antibody [31], was veriﬁed as shown in Supplementary
Fig. 4. Indeed, the CXCL12-induced migration of IKKβ KO MEFs was
rescued by the enforced expression of exogenous murine CXCR4; in
contrast, IKKα KO MEFs expressing similar levels of exogenously
introduced CXCR4 still failed to migrate towards CXCL12 (Fig. 3).
3.3. IKKα is required at the earliest phase of CXCL12-mediated cell
migration
To begin to explore the mechanism of action of IKKα in CXCL12 in-
duced cell migration, we dissected the migration parameters of WT vs.
induced IKKα KO primary MEFs in time-lapse microscopy experiments
Fig. 2. CXCR4 protein expression levels in Wt versus IKKβ conditional KO macrophages.
Mature macrophages derived from WT and myeloid cell conditional IKKβf/f:MLysCre
micewere stainedwith anti-CXCR4 antibody after cell permeabilization to reveal total cel-
lular CXCR4 protein expression (A), or without permeabilization to quantity cell surface
CXCR4 levels (B) and then analyzed by ﬂow cytometry. Data are shown as mean ﬂuores-
cence intensities (MFI) from 4 independent experiments and are expressed as fold change
of cells stimulated with CXLC12 (50 ng/ml) for 2 h vs. unstimulated cells. *p b 0.05 and
**p b 0.01 by one way ANOVA with Tukey's multiple comparisons post test.
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were performed with primary IKKαf/f;CreERT2MEFs sham-treated (WT
control) or treated with 4-OHT (IKKα induced deletion) in IBIDI μ slidesFig. 3. Enforcing CXCR4 expression rescues IKKβ but not IKKα cell migration towards
CXCL12. IKKβ and IKKα KOMEFs were stably transduced with a Moloney murine retrovi-
ral vector harboring a murine CXCR4 cDNA in a bi-cistronic IRES-puromycin expression
cassette (MuCXCR4-BIP). Cell surface CXCR4 expression was veriﬁed by ﬂow cytometry.
IKKα and IKKβ KO MEFs stably transduced with MuCXCR4-BIP and IKKβ KO MEFs as a
negative control were exposed for 3 h to CXCL12 (50 ng/ml) in a 48wellmicrochemotaxis
chamber. PDGF (10 ng/ml) served as the positive control for cell migration. Numbers
represent mean ± SEM of cells per high power ﬁeld (n = 5), *** = p b 0.001, NS = not
signiﬁcant.as previously described [30]. Immunoblotting conﬁrmed the ablation of
IKKα protein expression in IKKαf/f;CreERT2MEFs exposed to 4-OHT [30]
(Supplementary Fig. 1B). As shown in Fig. 4A, IKKα is required in prima-
ry MEFs for migration towards CXCL12, as it is in immortalized MEFs
(shown above in Fig. 1). The functional impact of IKKα for directional
chemotaxis is best determined at the earliest phase of the migration
response, which deﬁnes cellular polarization/orientation towards the
CXCL12 gradient. In this analysis, we deﬁned directional tracks as
those with ending points closer to the higher CXCL12 concentration in
the gradient, compared to their starting points, whilst non-directional
tracks are the opposite; and indeterminate tracks starting and ending
at the same distance from the CXCL12 gradient (moving laterally)
are also considered non-directional tracks {see detailed description
of how the IBIDI experiments were performed in Materials and
Methods} [30,43]. These time lapse time videomicroscopy experiments
revealed that IKKα is critical for determining initial cellular orientation/
polarization towards a CXCL12 gradient (compare directions of migra-
tion tracks inWT vs. induced IKKα KO cells in Fig. 4B and C respectively
and see statistically analyzed bar graph results summary in Fig. 4C). The
Euclidean distance (e.g. the straight line distance between starting and
arriving points) and velocity of all tracks were compared to each other
to ensure that all cells in the population were analyzed equally for
these two migration parameters independent of their directionality to
avoid biasing the results solely on the cells migrating directly towards
the CXCL12 gradient. Importantly, Figs. 4D and E reveal that IKKα is
also required for optimal Euclidean migration distance and for the
degree of cellular velocity within the initial 60 min of the chemotactic
response to CXCL12.
3.4. CXCL12 up-regulates the NF-κB non-canonical pathway
Because the IKKα dependent NF-κB non-canonical pathway is re-
quired for the earliest phase of migration in response to CXCL12 (polar-
ization and initial velocity), these results suggest that the IKKα/p52/
RelB axis could be necessary to maintain a sufﬁcient basal level of a crit-
ical protein co-factor. In conjunction with such a mechanism, CXCL12
may also stimulate IKKα dependent p52 nuclear translocation to up-
regulate the expression of a subset of IKKα/RelB/p52-dependent
genes. To explore the latter possibility, MEFs were exposed to CXCL12
for up to 8 h and cytoplasmic and nuclear cell fractions were scored
for their levels of p100 (p52's precursor) and the processed p52 NF-κB
subunit. Representative immunoblots are shown in Fig. 5A–C with
lamin-B1 and β-tubulin serving as normalization/reference controls
for nuclear and cytoplasmic proteins respectively. Cells treated for a
similar durationwith anti-murine lymphotoxin β receptor (mLTβR) an-
tibody, an agonist which is known to robustly activate IKKα-dependent
non-canonical NF-κB signaling [46], served as a positive control. Quan-
titative densitometric analysis of multiple immunoblots of nuclear and
cytoplasmic extracts of WT vs. IKKα−/− cells indicate that CXCL12, as
we previously had shown for HMGB1 [30], modestly induces p52 nucle-
ar translocation in WT but not in IKKα−/−MEFs (Fig. 5E). In contrast,
and as expected, LTβR stimulation induced robust p100 N p52 process-
ing inWTMEFs,while no effectwas seen in IKKα null cells (Fig. 5E). The
reduced levels of cytoplasmic and nuclear p52 (in comparison to its
p100 precursor) observed in IKKα null MEFs in Fig. 5 are in agreement
with prior reports showing that IKKα is required tomaintain a constitu-
tive, basal level of cytoplasmic and nuclear p52 [46,47]. Indeed,
quantitative densitometric analysis of immunoblots frommultiple inde-
pendent experiments show that unstimulated IKKα KOMEFs present a
reduced degree of p100 N p52 processing (revealed by their relative
p52/p100 ratios) in comparison to WT MEFs (Fig. 5D). In contrast
to IKKα KO MEFs, similar independent experiments show that
unstimulated IKKβ KO MEFs present p52/p100 ratios of 85 ± 12.5%,
which are comparable to WT MEFs.
In light of the above biochemical observations, we next investigated
if IKKα was also required for the induction of RelB/p52 target gene
Fig. 4. Functional consequences of IKKα ablation on speciﬁc CXCL12 migration parameters. (A): IKKαf/f:CreERT2MEFs were incubatedwith or without 4-OHT (100 nM) for 36 h, and mi-
gration assayswere performedusing serum freemedium(SF), or in response to the samemedia containing CXCL12 (30 ng/ml) or thepositive control PDGF (10 ng/ml). Numbers represent
mean± SEMof cells per high power ﬁeld (n=3), **= p b 0.01, *= p b 0.05, NS=not signiﬁcant. (B and C): Cells were exposed to CXCL12 gradients (0–30 ng/ml) in μ slides for 1 h, and
their movement was recorded by time-lapse microscopy. Red lines are tracks of cells moving in the direction of the CXCL12 gradient, and black lines are cell tracks moving in other direc-
tions. The difference in the number of directional and non-directional tracks betweenWT and the IKKα ablated MEFs is statistically signiﬁcant (χ2 test **p b 0.01); and bar graphs sum-
marizing these results are shown to the right of panel C. (D and E): WT and IKKα KO (4-OHT treated) cell tracks in Panels B & C were analyzed for their relative Euclidean distances and
velocities, *p b 0.05 and **p b 0.01 by two-tailed Student's t tests.
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known direct target of RelB/p52 NF-κB heterodimers, we analyzed
CXCL12 mRNA expression levels by qRT-PCR in WT and IKKα KO
MEFs in response to CXCL12 with LTβ receptor activation serving as a
positive control. Indeed as shown in Fig. 6, CXCL12 is a modest IKKα-
dependent inducer of its own expression.4. Discussion
Cell migration is a sophisticated, multi-step process critical for ani-
mal development, innate and adaptive immunity and the recognition
and repair of damaged tissue. Inappropriate and/or dysregulated
cell migration contributes to the progression of cancers, poor wound
healing, inﬂammatory-induced tissue injury and other maladies
{reviewed in [48,49]}.4.1. Cell migration responses towards CXCL12 aremechanistically related to
chemotactic responses to HMGB1
CXCL12 (SDF-1), along with HMGB1, belong to a small group of
chemoattractants that are essential for stem cell trafﬁcking [50–54].
Consequently, these molecules are critically important for the recogni-
tion and repair of damaged tissue in vivo [50,53,54]. Extracellular
HMGB1 engages the cell surface Receptor for Advanced Glycation End-
products (RAGE) and thereby elicits a range of inﬂammatory reactions
by acting as a cytokine and chemoattractant [33,34,55,56]. The pertussis
toxin sensitivity of HMGB1 chemotactic responses suggested early on
that at least one G-protein coupled receptor is also required for
HMGB1-mediated cell migration responses [57]; and recent work by
our lab and others has shown that CXCR4 functions as this essential
receptor for HMGB1-mediated cell migration responses [31,58].
HMGB1 forms functional complexes with a variety of endogenous and
Fig. 5. CXCL12 is a modest, IKKα-dependent inducer of NF-kB p52 nuclear translocation. (A) ImmortalizedWT or (B and C) IKKα−/−MEFs were stimulatedwith either 50 ng/ml CXCL12,
100 ng/ml HMGB1 or 10 μg/ml of an antagonistic anti-LTβR antibody for the indicated times. S refers to CXCL12/SDF-1 and H denotes HMGB1. Nuclear and cytoplasmic protein fractions
were analyzed bywestern blotting as shownwith p100 and p52 identiﬁed by an anti-p100/p52 antibody. The asterisk in the immunoblot denotes a cross-reactive artifact band in the anti-
p52 nuclear extracts. Immunoblots were stripped and re-probed with antibodies against Lamin B1 or β-Tubulin as protein loading controls for nuclear and cytoplasmic cell fractions, re-
spectively. (D) Comparative analysis of p52:p100 levels in un-stimulatedWT vs. unstimulated IKKα KOMEFs from 3 independent experiments (one of which is shown in panels A-C). (E)
Densitometric quantiﬁcation of p52 nuclear import in WT and IKKα−/− cells in response to HMGB1, CXCL12/SDF-1 or LTβR stimulations at the 8 h time point. Numbers represent 3 in-
dependent experiments. p52 signalswere all normalized to lamin B1 as a nuclear protein reference control. Error bars are standard error of themean. *P b 0.05; **P b 0.01; ***P b 0.001 by
two-tailed Student's t tests.
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to dramatically enhance inﬂammatory responses [59–62]; and HMGB1-
partner complexes signal through the speciﬁc partner molecule's
receptor, independent of HMGB1 receptors, to dramatically enhance
the production of cytokines associated with inﬂammatory responses
[63]. Recently, we reported that theHMGB1-mediated cellmigration re-
sponses require extracellular CXCL12, which is secreted by cells migrat-
ing towards HMGB1 [31,64]. HMGB1 forms functional complexes with
CXCL12 [64]; and the mechanism of cell migration towards HMGB1 in-
volves HMGB1–CXCL12 complexes signaling via CXCR4 [31,58], whichis believed to be sufﬁcient to drive cell migration towards HMGB1 in
the absence of other HMGB1 receptors [58]. Interestingly, CXCL12 liga-
tion of CXCR4 activates someof the samepathways asHMGB1 including
canonical NF-κB signaling, moreover, CXCR4 [6,8] and its ligand CXCL12
[46,65], are direct targets of the IKKβ-dependent canonical and IKKα-
dependent non-canonical NF-κB pathways, respectively. Importantly
and unlike other cell migratory responses, we have previously shown
that chemotaxis to HMGB1 or CXCL12 in vitro and in vivo uniquely re-
quires activating of the canonical NF-κB pathway [9,57]. Furthermore,
we have also previously shown that the IKKβ/canonical and IKKα/
Fig. 6. CXCL12 up-regulated the level of its mRNA with a dependency on IKKα. Real time
RT-PCR analysis of CXCL12 mRNA expression in WT and IKKα−/− MEFs in response
to CXCL12 or LTβR stimulation. Data were normalized to GAPDH mRNA qRT-PCRs as a
reference control. +P b 0.05.
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for HMGB1 chemotactic responses in vitro and in vivo [30,31], with
IKKβ signaling necessary to maintain sufﬁcient levels of RAGE [30];
and IKKα signaling essential for maintaining a sufﬁcient expression of
its direct target CXCL12 for cells to migrate towards HMGB1/CXCL12
complexes [31,58]. In this new study we present evidence that
the IKKβ and IKKα-driven NF-κB signaling pathways are also both
essential for cell migration to CXCL12 alone, independent of HMGB1,
thereby linking the regulation of cell migration to the two unique
chemoattractants mediating cell recruitment to damaged tissues.4.2. IKKβ and IKKα-dependent NF-κB signaling are simultaneously
essential for directed cell movement towards CXCL12/SDF-1
Our data collectively points to constitutive IKKβ-dependent canoni-
cal NF-κB signaling as essential to maintain a speciﬁc threshold level of
cell surface CXCR4, the sole receptor that positively mediates directed
cell migration to CXCL12. Thus, on the basis of the new data presented
here and our prior work [30], IKKβ-dependent canonical NF-κB signal-
ing works by a common mechanism of action to regulate chemotactic
responses to HMGB1 and CXCL12 by maintaining sufﬁcient expression
levels of the receptors for these two cytokines.
In contrast, the critical need for IKKα-dependent non-canonical
NF-κB p52/RelB activation for cell migration towards CXCL12 is not
linked to CXCR4 expression levels. Although the precise downstream
target of the non-canonical NF-κB IKKα/p52/RelB signaling axis needed
for cellmigration to CXCL2 remains to be identiﬁed, our time lapse video
microscopy experiments reveal that IKKα is required for the initial
cell orientation/polarization and velocity towards a CXCL12 gradient.
Taken collectively, along with our cell fractionation experiments show-
ing that IKKα up-regulates the basal level of p100 N p52 processing, our
results herein provide evidence that cells migrating towards CXCL12
require the IKKα/p52/RelB pathway to maintain a sufﬁcient level of a
critical effector/adaptor of CXCR4-mediated CXCL12 signaling that is
speciﬁcally needed for cell migration to CXCL12 alone. In contrast, cell
migration towards HMGB1/CXCL12 complexes are believed to signal
via an alternate conformation of the CXCR4 receptor [58].
In summary, we posit that the IKKα/p52/RelB pathway functions in
a constitutive fashion tomaintain basal levels of this putative CXCR4 sig-
naling effector/co-factor; and our future work will in part be directed to
identify this potentially novel regulatory protein factor.5. Conclusions
Our experiments show that IKKβ and IKKα are each essential for cell
migration towards CXCL12 for different reasons. The results demon-
strate that IKKβ is needed to maintain a threshold level of cell surface
CXCR4, the CXCL12 receptor, while the dual requirement for IKKα is
not linked to CXCR4 expression. Time lapse video microscopy analysis
performed with inducible IKKα KO primary ﬁbroblasts reveal that the
essential need for IKKα becomes apparent within the initial 30-60
min of a CXCL12 chemotactic response, as IKKα appears to be critical
for both initial cell polarization and velocity towards CXCL12. We also
present evidence that CXCL12 is a modest iIKKα-dependent inducer of
NF-κB p52 nuclear translocation and also up-regulates its own IKKα/
RelB/p52-dependent expression. Because IKKα up-regulates the basal
level of p100 N p52 processing and is essential at the earliest phase of
CXCL12-mediated cell migration, taken together our data suggests
that IKKα is required to maintain the basal expression of a critical
NF-κB p52/RelB target gene, which is required for CXCL12-mediated
cell migration.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.04.011.
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